Andre Marion is listed as a director on 9 SEC Form D filings by 3 issuers between Mar 2011 and Jun 2013: IntegenX Inc (Pleasanton, CA — biotechnology — 2011–2012; $48.8M reported sold to 16 investors), Singulex, Inc. (Alameda, CA — biotechnology — 2011–2013; $15.3M reported sold to 8 investors) and Labcyte Inc (Sunnyvale, CA — biotechnology — 2013; $5.79M reported sold to 18 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $70M sold in total.
Listed alongside Carl L. Gordon (4 shared filings), David Barker (4 shared filings), Dennis Harris (4 shared filings), Fred K. Vogt (4 shared filings), Gregory R. Johnson (4 shared filings) and 25 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Andre. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 9 public filings for Andre Marion and found 6 differences, 1 worth asking the sponsor about: Andre Marion is no longer listed on the Sep 20, 2013 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.